Discovery of LHF418 as a new potent SOS1 PROTAC degrader-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of LHF418 as a new potent SOS1 PROTAC degrader

Published:2024-04 Issue: Volume:103 Page:117661
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Li Huifan,Chai Minxue,Chen Yihan,Zhou Fengtao,Ren Xiaomei,Xu Jian,Wang Jian,Wang Zhen,Huang Weixue

Funder

Ningbo Municipal Natural Science Foundation

Shanghai Municipality Science and Technology Commission

Publisher

Elsevier BV

Reference20 articles.

1. RAS-targeted therapies: is the undruggable drugged?;Moore;Nat Rev Drug Discov,2020

2. Molecular epidemiology and diagnostics of KRAS mutations in human cancer;Timar;Cancer Metastasis Reviews,2020

3. Targeting RAS oncogenesis with SOS1 inhibitors;Hillig;Adv Cancer Res,2022

4. The current state of the art and future trends in RAS-targeted cancer therapies;Punekar;Nat Rev Clin Oncol,2022

5. Kinetics of interaction of nucleotides with nucleotide-free H-ras p21;John;Biochemistry,1990

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted protein degradation as an innovative therapeutic modality for oral squamous cell carcinoma;Oral Oncology Reports;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP